Advertisement

HDL particle size: a marker of the gender difference in the metabolic risk profile

      Abstract

      A low plasma HDL-cholesterol concentration is an important risk factor for coronary heart disease (CHD) and is often accompanied by increased triglyceride concentrations. Women have generally higher HDL-cholesterol and lower triglyceride concentrations and concomitantly are at lower risk of CHD than men. As HDL particle size is a new and potentially important marker of CHD risk, we have examined the potential gender difference in HDL particle size, assessed by nondenaturing 4–30% polyacrylamide gradient gel electrophoresis, in a sample of men (n=231) and women (n=183). Overall, men were characterized by a less favorable lipoprotein–lipid profile, which was accompanied by smaller HDL particle size compared to women. However, when men and women were matched for HDL particle size and compared for their metabolic profile, it was found that both genders were characterized by similar plasma lipoprotein–lipid profile despite the fact that women were characterized by higher levels of total body fat but lower waist girth than men. In summary, HDL particle size is a strong marker of the gender-related difference in the determination of the metabolic risk profile.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wilson H.M.
        • Patel J.C.
        • Skinner E.R.
        The distribution of high-density lipoprotein subfractions in coronary survivors.
        Biochem Soc Trans. 1990; 18: 1175-1176
        • Lamarche B.
        • Moorjani S.
        • Cantin B.
        • Dagenais G.R.
        • Lupien P.J.
        • Després J.P.
        Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.
        Arterioscler Thromb Vasc Biol. 1997; 17: 1098-1105
        • Johansson J.
        • Carlson L.A.
        • Landou C.
        • Hamsten A.
        High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.
        Arterioscler Thromb. 1991; 11: 174-182
        • Cheung M.C.
        • Brown B.G.
        • Wolf A.C.
        • Albers J.J.
        Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease.
        J Lipid Res. 1991; 32: 383-394
        • Anderson K.M.
        • Castelli W.P.
        • Levy D.
        Cholesterol and mortality. 30 years of follow-up from the Framingham study.
        J Am Med Assoc. 1987; 257: 2176-2180
        • Brown S.A.
        • Hutchinson R.
        • Morrisett J.
        • et al.
        Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study.
        Arterioscler Thromb. 1993; 13: 1139-1158
        • Li Z.
        • McNamara J.R.
        • Fruchart J.C.
        • et al.
        Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes.
        J Lipid Res. 1996; 37: 1886-1896
        • Ohta T.
        • Hattori S.
        • Murakami M.
        • Nishiyama S.
        • Matsuda I.
        Age- and sex-related differences in lipoproteins containing apoprotein A-I.
        Arteriosclerosis. 1989; 9: 90-95
        • Lemieux S.
        • Després J.P.
        • Moorjani S.
        • et al.
        Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?.
        Diabetologia. 1994; 37: 757-764
        • Li Z.
        • McNamara J.R.
        • Ordovas J.M.
        • Schaefer E.J.
        Analysis of high density lipoproteins by a modified gradient gel electrophoresis method.
        J Lipid Res. 1994; 35: 1698-1711
        • Blanche P.J.
        • Gong E.L.
        • Forte T.M.
        • Nichols A.V.
        Characterization of human high-density lipoproteins by gradient gel electrophoresis.
        Biochim Biophys Acta. 1981; 665: 408-419
        • Krauss R.M.
        • Nichols A.V.
        Metabolic interrelationships of HDL subclasses.
        Adv Exp Med Biol. 1986; 201: 17-27
        • Cheung M.C.
        • Albers J.J.
        Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.
        J Biol Chem. 1984; 259: 12201-12209
      1. Behnke AR, Wilmore JH. Evaluation and regulation of body build and composition. Englewood Cliffs. NJ: Prentice-Hall; 1974. p. 230.

        • Meneely G.R.
        • Kaltreider N.L.
        Volume of the lung determined by helium dilution.
        J Clin Invest. 1949; 28: 129-139
        • Siri W.E.
        The gross composition of the body.
        Adv Biol Med Phys. 1956; 4: 239-280
      2. Lohman T, Roche A, Martorel R, editors. The Airlie (VA) consensus conference standardization of anthropometric measurements. Standardization of anthopometric measurements. Champaign, IL: Human Kinetics, 1988. p. 39–80.

        • Ferland M.
        • Després J.P.
        • Tremblay A.
        • et al.
        Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements.
        Br J Nutr. 1989; 61: 139-148
        • Albers J.J.
        • Warnick G.R.
        • Wiebe D.
        • et al.
        Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein.
        Clin Chem. 1978; 24: 853-856
        • Gidez L.I.
        • Miller G.J.
        • Burstein M.
        • Slage S.
        • Eder H.H.
        Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.
        J Lipid Res. 1982; 23: 1206-1223
        • Laurell C.B.
        Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.
        Anal Biochem. 1966; 15: 45-52
        • Moorjani S.
        • Dupont A.
        • Labrie F.
        • et al.
        Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.
        Metabolism. 1987; 36: 244-250
        • Richterich R.
        • Dauwalder H.
        Zur bestimmung der plasmaglukosekonzentration mit der hexokinase- glucose-6-phosphat-dehydrogenase-methode.
        Schweiz Med Wochenschr. 1971; 101: 615-618
        • Desbuquois B.
        • Aurbach G.D.
        Use of polyethylene glycol to separate free and antibody- bound peptide hormones in radioimmunoassays.
        J Clin Endocrinol Metab. 1971; 37: 732-738
        • Sich D.
        • Saidi Y.
        • Giral P.
        • et al.
        Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
        Metabolism. 1998; 47: 965-973
        • Lemieux I.
        • Pascot A.
        • Dumont M.
        • et al.
        Is the high triglyceride-low HDL cholesterol atherogenic dyslipidemia a small, dense LDL or HDL phenotype? (abstract).
        Atherosclerosis. 2000; 151: 98
      3. Pascot A, Lemieux I, Prud'homme D, et al. The small, dense HDL phenotype: a marker of the atherogenic metabolic triad (hyperinsulinemia, elevated apolipoprotein B and small, dense LDL particles)? (abstract). Circulation 2000.

        • Williams P.T.
        • Vranizan K.M.
        • Austin M.A.
        • Krauss R.M.
        Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses.
        Arterioscler Thromb. 1993; 13: 1654-1661
        • Goodman-Gruen D.
        • Barrett-Connor E.
        Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women.
        Diab Care. 2000; 23: 912-918
        • Brinton E.A.
        • Eisenberg S.
        • Breslow J.L.
        Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.
        J Clin Invest. 1989; 84: 262-269
        • Brinton E.A.
        • Eisenberg S.
        • Breslow J.L.
        Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
        Arterioscler Thromb. 1994; 14: 707-720
        • Brinton E.A.
        • Eisenberg S.
        • Breslow J.L.
        Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
        J Clin Invest. 1991; 87: 536-544
        • Brinton E.A.
        • Eisenberg S.
        • Breslow J.L.
        A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
        J Clin Invest. 1990; 85: 144-151
        • Lamarche B.
        • Uffelman K.D.
        • Steiner G.
        • Barrett P.H.
        • Lewis G.F.
        Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model.
        J Lipid Res. 1998; 39: 1162-1172